Literature DB >> 3691603

Hepatic enzyme induction and vitamin K1 elimination in man.

A K Scott1, B P Haynes, K D Schinkel, E E Ohnhaus, B K Park.   

Abstract

We have studied the effect of hepatic enzyme induction on vitamin K1 elimination in patients on long-term anticonvulsant therapy and in volunteers given rifampicin. Neither the anticonvulsants (phenytoin and phenobarbitone) nor rifampicin had any significant effect on vitamin K1 elimination half-life or AUC. The neonatal haemorrhage which occurs in babies born to mothers on long-term enzyme inducing drugs is unlikely to be related to an increased rate of vitamin K elimination in the mother.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691603     DOI: 10.1007/bf00610388

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.

Authors:  T J Hahn; B A Hendin; C R Scharp; J G Haddad
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

2.  Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

Authors:  K R Mountain; J Hirsh; A S Gallus
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

3.  Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother.

Authors:  M F Deblay; P Vert; M Andre; F Marchal
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

4.  Quantitative analysis of pharmacological levels of vitamin K1 and vitamin K1 2,3-epoxide in rabbit plasma by high-performance liquid chromatography.

Authors:  A C Wilson; B K Park
Journal:  J Chromatogr       Date:  1983-10-14

5.  Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.

Authors:  B K Park; A K Scott; A C Wilson; B P Haynes; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

6.  A pharmacokinetic program for TI-59.

Authors:  F Nielsen-Kudsk
Journal:  J Pharmacol Methods       Date:  1980-06

7.  A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine.

Authors:  B K Park
Journal:  J Steroid Biochem       Date:  1978-10       Impact factor: 4.292

8.  Enzyme induction by phenobarbitone and vitamin K1 disposition in man.

Authors:  B K Park; A C Wilson; G Kaatz; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

9.  Precursor prothrombin status in patients receiving anticonvulsant drugs.

Authors:  V A Davies; A D Rothberg; A C Argent; P M Atkinson; H Staub; N L Pienaar
Journal:  Lancet       Date:  1985-01-19       Impact factor: 79.321

10.  Preparative isolation and characterization of the urinary aglycones of vitamin K1 (phylloquinone in man.

Authors:  A McBurney; M J Shearer; P Barkhan
Journal:  Biochem Med       Date:  1980-12
View more
  2 in total

Review 1.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953

2.  Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors.

Authors:  Yuan Lu; Jinbo Yang; Haiyan Zhang; Jin Yang
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.